LeukopeniaDrug EvaluationThrombocytopeniaAntineoplastic Combined Chemotherapy ProtocolsDrug Administration ScheduleLeukocyte CountCisplatinFluorouracilInfusions, IntravenousPaclitaxelHematologic DiseasesNeutropeniaTreatment OutcomeDoxorubicinAntineoplastic Agents, PhytogenicBlood Cell CountCyclophosphamideLung NeoplasmsAntineoplastic AgentsCombined Modality TherapyCellophaneGastric FistulaVinblastineCarboplatinEtoposideNauseaTaxoidsBone Marrow DiseasesAnemiaLeukocytesSurvival AnalysisPhlebovirusBone MarrowMenogarilDose-Response Relationship, DrugEhrlichiaGranulocyte Colony-Stimulating FactorDeoxycytidineCamptothecinAminopterinEhrlichiosisLevamisoleSurvival RateMycophenolic AcidAntimetabolites, AntineoplasticVomitingLeucovorinNogalamycinAlopeciaDisease-Free SurvivalAzathioprineCarcinoma, Small CellCarcinoma, Non-Small-Cell LungStomatitisPlatelet CountBunyaviridae InfectionsRemission InductionRickettsiaceae InfectionsNeoplasmsMaximum Tolerated DoseNeoplasm MetastasisFeverErythrocyte CountIfosfamideAntineoplastic Agents, AlkylatingPneumonia, StaphylococcalGranulocytesAgranulocytosisTime FactorsImmunosuppressive AgentsMethotrexatePancytopeniaMechlorethamineSalvage TherapyNeoplasm Recurrence, LocalTegafurNeoplasm StagingInfusions, Parenteral6-MercaptopurineVincristineChemotherapy, AdjuvantOvarian NeoplasmsBreast NeoplasmsEhrlichia chaffeensisProspective StudiesAdministration, OralRecombinant ProteinsEpothilonesAdenocarcinomaEpirubicinInterferon-alphaRecurrencePlatinumEndotoxins